MMP14 and breast carcinoma: On the other hand, in ΕRα-negative breast cancer patients under systemic treatment (Figure 1B), MMP14 expression related, in a statistically significant manner, to poor survival confirming its implication to the invasive and aggressive phenotype of ΕRα-negative breast cancer cells, such as in the case of triple-negative breast cancer (Figure 1C).